Chikako Shimizu

Can oncologists predict survival for patients with progressive disease after standard chemotherapies?

Akihiro Hirakawa, Kenji Tamura, Tomoko Taniyama, 2014, Current oncology.

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

Yasuhiro Fujiwara, Tsutomu Kouno, Yasuhiro Yamanaka, 2006, Journal of Cancer Research and Clinical Oncology.

FOXP1, an Estrogen-Inducible Transcription Factor, Modulates Cell Proliferation in Breast Cancer Cells and 5-Year Recurrence-Free Survival of Patients with Tamoxifen-Treated Breast Cancer

Akihiko Osaki, Hitoshi Tsuda, Satoshi Inoue, 2011, Hormones & cancer.

A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

Tatsuya Morita, Masanori Mori, Saran Yoshida, 2015, The oncologist.